# Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

> **NCT03106532** · PHASE2 · COMPLETED · sponsor: **pH Pharma** · enrollment: 119 (actual)

## Conditions studied

- Normal Tension Glaucoma

## Interventions

- **DRUG:** PHP-201 0.25% ophthalmic solution
- **DRUG:** PHP-201 0.5% ophthalmic solution
- **DRUG:** Placebo ophthalmic solution

## Key facts

- **NCT ID:** NCT03106532
- **Lead sponsor:** pH Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-06
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2018-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106532, "Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03106532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*